Swiss cannabis market: which figures are dependable?

Consumption surveys, CBD revenue and pilot studies describe different things. This guide explains what a market estimate needs to disclose and why a survey does not establish sales revenue.

TL;DR: A dependable market figure identifies its segment, period, population, method and source. Without these details, we do not publish a blanket revenue total or general growth forecast here.

Define the market before measuring it

What does a report mean by the “cannabis market”? It might cover CBD consumer goods, medical applications or an informal market. These areas have different rules and evidence bases. Adding them together without explaining the boundaries produces a total that is difficult to interpret.

A company’s Swiss location does not establish that every sale reaches a Swiss customer. Domestic sales, exports and wholesale transactions need separate treatment. Counting the same goods at several distribution stages can also inflate the result unintentionally.

Consumption prevalence does not measure revenue

MonAM presents cannabis-use data from the 2022 Swiss Health Survey. Our consumption page explains the findings and the age group covered. The survey year is distinct from this article’s editorial review date.

Reporting use during the previous twelve months does not establish daily use or a particular amount spent. Deriving revenue from that result would require further assumptions. Such a calculation should remain recognisable as a model, rather than looking like directly observed sales income.

What a revenue estimate should disclose

A financial total becomes useful when its scope is clear. Which products and businesses were included? Does it cover consumer sales or transactions between businesses? Are exports, taxes and multiple distribution stages part of the calculation?

A documented uncertainty range explains more than a highly precise number without an accessible calculation. Comparability matters too: a new method or different segment can create an apparent growth trend. A recent publication alone does not demonstrate an actual market change.

Keep pilot studies and political plans separate

Participants in an authorised trial are not a representative census of cannabis consumption throughout Switzerland. A project count also needs a date and a definition: registrations, current participants and completed participation are different measures.

A debate about reform does not describe a market that has already opened. The existing pilot and current-law overviews explain this institutional context. Without further evidence, they cannot establish nationwide revenue or guarantee future sales.

How we assess figures before updating this page

This page separates verifiable survey findings from unconfirmed commercial estimates. Previous blanket revenue totals, export volumes, shop counts and annual growth rates were removed because their derivation was not supported here by an accessible original document.

A future addition needs a verifiable original source and a clear explanation of its limitations. Without that evidence, the figure remains unresolved. This provides readers and systems citing our content with a more dependable reference.

FAQ

How large is Switzerland’s CBD market?

We do not give a total revenue figure without an explicit scope and verifiable original source.

Are consumers and purchasers the same measure?

No. A consumption survey establishes neither individual spending nor revenue for a market segment.

Does a 2026 update mean the data were collected in 2026?

No. Survey period, publication and editorial verification are treated separately.

Do pilot studies represent the national market?

Not automatically. A study population and the national population are different reference groups.

Sources & references